Study Shows Vision, Anatomy Stable With Port System for AMD
Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.
United States David Massop Genentech Roche Charles Wykoff American Society Of Retina Specialists Regeneron Pharmaceuticals
Source: medscape.com